Cell programming biotech bit.bio is slimming its workforce by 25% as the company pivots to focus on biomedical tools instead of therapeutics development. The decision was driven by “shifting ...

Cargo Therapeutics, a once-high-flying Bay Area biotech company that specializes in oncology research, is laying off almost its entire staff as it shuts down drug development efforts. Cargo’s ...

One day, the nitroplast may revolutionize farming. "It's one of the Holy Grails of biotechnology," says Jon Zehr, a now-retired microbial ecologist from UC Santa Cruz — the ability to engineer ...

The Cambridge, Massachusetts-based biotech is closing “following careful consideration of potential paths forward and strategic factors,” HC CEO and cofounder Leslie Williams said in an ...

The 10 most innovative biotech companies of 2025 are leveraging AI to find new drugs, match patients with the best treatments, and even support biodiversity research. This year’s list of biotech ...

The Biotech Bay Hotbed includes the San Francisco Bay, Menlo Park and Palo Alto regions of Northern California. California is a dominant force in the life sciences sector, hosting global leaders and ...

A Boston biotech try­ing to bring trans­fer RNA (tR­NA) bi­ol­o­gy to the drug de­vel­op­ment field has shut­tered op­er­a­tions, End­points News has learned.

AstraZeneca has struck a deal to acquire biotechnology company EsoBiotec for up to $1bn, as the London-listed pharmaceutical group expands its investments in cell therapies for treating cancer.

AstraZeneca is bolstering its cell therapy capabilities, agreeing on Monday to pay up to $1 billion for a biotechnology startup making treatments that reprogram cells inside the body. The British ...